PMID: 601870Dec 1, 1977Paper

Lymph node tuberculosis: a comparison of various methods of treatment

Tubercle
I A Campbell, A J Dyson

Abstract

The treatment of lymph node tuberculosis has been studied in 108 patients. Chemotherapy consisted of 18 months' isoniazid with either rifampicin or ethambutol, plus an initial supplement of streptomycin. These 2 regimens were randomly allocated to 19 patients who had previously undergone excision of the lymph nodes, 56 patients who had undergone biopsy and 33 patients who had not had any surgical procedures. The majority of patients were of Indian or Pakistani origin (80%). Histological evidence of tuberculosis was obtained in 64% of the 108 patients and M. tuberculosis was cultured in 30%. No other mycobacteria were grown. Progress during treatment was uneventful in 65% of patients. Fresh nodes appeared during treatment in 12%, existing nodes enlarged in 13% and fluctuation developed in 11% of patients. Discharge and/or sinus formation was infrequent (7%), as was breakdown of a surgical scar (4%). Excision or aspiration after the start of chemotherapy was performed in 19% of patients. In the period up to the end of chemotherapy no difference emerged between the patients who received rifampicin with isoniazid and those who received ethambutol with isoniazid. Satisfactory results were obtained in 98% of the patients by the end o...Continue Reading

References

Feb 1, 1976·Journal of Pediatric Surgery·A MacKellar
Jan 26, 1974·British Medical Journal·P B Iles, P A Emerson
Nov 1, 1971·Postgraduate Medical Journal·J F Newcombe
Sep 14, 1957·British Medical Journal·G S KILPATRICK, A C DOUGLAS
Mar 1, 1963·Tubercle·P M GILLAM, J P KNOWLES

❮ Previous
Next ❯

Citations

Nov 1, 1995·Indian Journal of Pediatrics·S KumarC Sharma
Apr 25, 2012·Zeitschrift für Rheumatologie·D Meyer-OlsonM Stoll
May 2, 2013·Travel Medicine and Infectious Disease·Geetanjali Reddy BelumB S N Reddy
Apr 1, 1993·Seminars in Roentgenology·G A AgronsS S Kramer
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charlotte R HawkeyRobert J Wilkinson
Dec 14, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Willemien A NienhuisTjip S van der Werf
Jul 9, 1998·The Pediatric Infectious Disease Journal·A B ChangA Olinsky
Dec 29, 2012·The Pediatric Infectious Disease Journal·Carole OliveJack Levy
Jun 2, 2009·Current Opinion in Infectious Diseases·Hsin-Yun Sun, Nina Singh
Jan 1, 1993·Journal of Internal Medicine·V NayyarP Khanduri
Aug 1, 1996·Australian and New Zealand Journal of Medicine·E GabbayF R Lake
Jul 14, 2005·HIV Medicine·A L PozniakUNKNOWN BHIVA Guidelines Writing Committee
Sep 29, 2011·HIV Medicine·A L PozniakUNKNOWN BHIVA Guidelines Subcommittee
Oct 14, 2009·Clinical Microbiology Reviews·Patricia PriceMartyn A French
Aug 18, 1990·BMJ : British Medical Journal·M S JawaharR Prabhakar
Sep 1, 1982·Journal of Epidemiology and Community Health·J GrangeM Yates
Apr 20, 1999·Radiology·A N Leung
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·M NaritaA E Pitchenik
Jul 1, 2008·Lung India : Official Organ of Indian Chest Society·Vishal ChopraDimple Chopra
Jul 31, 2002·Radiology·Yo Won ChoiKyung Bin Joo
Feb 18, 2005·European Radiology·A I De BackerM M Kockx
Aug 1, 1985·The Journal of Hygiene·E G Wilkins, C Roberts
Jan 1, 1990·The Journal of Laryngology and Otology·S K LauU C Engzell
Feb 18, 2003·American Journal of Respiratory and Critical Care Medicine·Henry M BlumbergUNKNOWN American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society
Oct 12, 2015·Pediatric Radiology·Shai ShrotMichalle Soudack
Jul 14, 2001·Chest·K A WendelT R Sterling
Apr 12, 2002·Chest·Henning GeldmacherDetlef K Kirsten
Jun 23, 2009·Medicina clínica·Angel Fernández-Fúnez
Jun 19, 2009·The Journal of Infection·Oh-Hyun ChoSung-Han Kim
Nov 3, 2005·Tropical Medicine & International Health : TM & IH·M S JawaharR Prabhakar
Oct 1, 1980·British Journal of Diseases of the Chest·G D Summers, M W McNicol
Jun 1, 1988·Tubercle·J K Onwubalili, G M Scott
Dec 1, 1992·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·Y M ChenR P Perng
Dec 1, 1996·The British Journal of Oral & Maxillofacial Surgery·C N Penfold, P J Revington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.